[{"data":1,"prerenderedAt":63},["ShallowReactive",2],{"q-nurse-112-1-medical-surgical-048":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":34,"lastmod":62},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":25},"nurse-112-1-內外科護理學-048","nurse-112-1-medical-surgical-048",112,1,48,"有關器官移植前的組織配對，降低排斥反應之檢驗項目，不包含下列何者？",{"A":14,"B":15,"C":16,"D":17},"ABO 及 Rh 血型","人類白血球抗原","交叉配對試驗","梅毒血清檢查","D",null,[],"本題考點在於器官移植前為降低排斥所做的組織配對項目，屬反向題須找出不屬於配對的項目。不包含的是 D 梅毒血清檢查：梅毒血清屬感染性疾病篩檢，目的在防止病原經移植傳播，與組織相容性、排斥反應無關，選 D。A 正確，ABO 及 Rh 血型須相容以避免超急性排斥；B 正確，人類白血球抗原（HLA）配對愈相符排斥愈低；C 正確，交叉配對試驗檢測受贈者血清中是否已有對抗捐贈者的抗體，避免超急性排斥。","移植免疫學核心是 HLA（MHC）系統，配對重點為 HLA-A、B、DR 位點。超急性排斥源於受者體內既存抗體（ABO 不合或先前致敏），故術前必做交叉配對。梅毒、B\u002FC 肝、HIV 等屬傳染病篩檢範疇，與相容性分屬兩條軸線。可連結排斥分類：超急性（分鐘至小時）、急性（數日至數月，細胞性為主）、慢性（數月至數年）。",[24,26,28,30,32],{"term":16,"count":25},2,{"term":27,"count":10},"組織配對",{"term":29,"count":10},"HLA 人類白血球抗原",{"term":31,"count":10},"ABO\u002FRh 血型",{"term":33,"count":10},"梅毒血清為感染篩檢",[35,39,43,48,53,58],{"webId":36,"stem":37,"number":38,"year":9,"session":10},"nurse-112-1-medical-surgical-049","有關全身性紅斑性狼瘡病人之護理指導，下列何者錯誤？",49,{"webId":40,"stem":41,"number":42,"year":9,"session":25},"nurse-112-2-medical-surgical-065","有關腎臟移植之合併症，下列敘述何者不適當？",65,{"webId":44,"stem":45,"number":46,"year":47,"session":10},"nurse-113-1-medical-surgical-029","有關疥瘡的治療，下列敘述何者正確？",29,113,{"webId":49,"stem":50,"number":51,"year":52,"session":25},"nurse-114-2-medical-surgical-027","有關腫瘤溶解症候群之處置，下列何者錯誤？",27,114,{"webId":54,"stem":55,"number":56,"year":57,"session":10},"nurse-106-1-medical-surgical-031","急性心肌梗塞後，下列何種心肌酶指標最快恢復正常？",31,106,{"webId":59,"stem":60,"number":42,"year":61,"session":10},"nurse-107-1-medical-surgical-065","有關早期慢性腎臟病病人服用血管收縮素轉化酶抑制劑（Angiotensin Converting Enzyme Inhibitors, ACEI）之敘述，下列何者錯誤？",107,"2026-09-04",1788510742132]